Citation Impact
Citing Papers
Protein characterization of Saccharomyces cerevisiae RNA polymerase II after in vivo cross-linking
2007 StandoutNobel
Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia
2017
Global phosphorylation analysis of β-arrestin–mediated signaling downstream of a seven transmembrane receptor (7TMR)
2010 StandoutNobel
Immune Rejection of Mouse Tumors Expressing Mutated Self
2009 StandoutNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response
2006
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
2015 Science
Exploiting the Mutanome for Tumor Vaccination
2012
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease
1998 Standout
High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo
1998
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Combinatorial Cancer Immunotherapy
2006
Activation of Low Avidity CTL Specific for a Self Epitope Results in Tumor Rejection But Not Autoimmunity
1998
T cell defined tumor antigens
1997
Progress in human tumour immunology and immunotherapy
2001 Nature
The shared tumor-specific antigen encoded by mouse geneP1A is a target not only for cytolytic T lymphocytes but also for tumor rejection
1998
Analysis of the T cell response to tumor and viral peptide antigens by an IFNγ-ELISPOT assay
1997
Overexpression of a DEAD Box Protein (DDX1) in Neuroblastoma and Retinoblastoma Cell Lines
1998
Autologous Dendritic Cells for Treatment of Advanced Cancer — An Update
2001
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Immunology and immunotherapy approaches for prostate cancer
2007
Immunotherapy of Hematologic Malignancy
2003
The Human T Cell Response to Melanoma Antigens
2006
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
2013
Enhanced Antigen-Specific Antitumor Immunity with Altered Peptide Ligands that Stabilize the MHC-Peptide-TCR Complex
2000
Human tumor antigens recognized by T-cells
1997
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen
2006
Cancer vaccines based on the identification of genes encoding cancer regression antigens
1997
The α Chain of the T Cell Antigen Receptor Is Degraded in the Cytosol
1997
Expression of tumour-specific antigens underlies cancer immunoediting
2012 Nature
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
HLA-A2 Restricted, Melanocyte-Specific CD8+ T Lymphocytes Detected in Vitiligo Patients are Related to Disease Activity and are Predominantly Directed Against MelanA/MART1
2001
Sources of diversity in T cell epitope discovery
2011
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Tumor‐specific shared antigenic peptides recognized by human T cells
2002
MHC ligands and peptide motifs: first listing
1995
The Cytoplasmic Tail of the Mouse Brown Locus Product Determines Intracellular Stability and Export from the Endoplasmic Reticulum
1998
Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?
1995
The impact of T‐cell immunity on ovarian cancer outcomes
2008
A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation
1999
Somatic misexpression of germline P granules and enhanced RNA interference in retinoblastoma pathway mutants
2005 StandoutNatureNobel
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Human tumor antigens for cancer vaccine development
1999
Taking dendritic cells into medicine
2007 StandoutNatureNobel
T cell antigen discovery via trogocytosis
2019 Nobel
NY‐ESO‐1: Review of an Immunogenic Tumor Antigen
2006
Quantitative reactivity profiling predicts functional cysteines in proteomes
2010 StandoutNatureNobel
Impact energy measurement in time-of-flight mass spectrometry with cryogenic microcalorimeters
1998 StandoutNatureNobel
Functional Proteomics Reveals the Biochemical Niche of C. elegans DCR-1 in Multiple Small-RNA-Mediated Pathways
2006 StandoutNobel
A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens
1999
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Identification of human tumor antigens and its implications for diagnosis and treatment of cancer
2004
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Global quantification of mammalian gene expression control
2011 StandoutNature
The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells
2005
Novel tools to assist neoepitope targeting in personalized cancer immunotherapy
2017
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
In vivoblockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance
1999 StandoutNobel
The HLA-A*0201-Restricted H-Y Antigen Contains a Posttranslationally Modified Cysteine That Significantly Affects T Cell Recognition
1997
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
1996
The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol
1998
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals
1999
Functional Reconstitution of Class II MHC-Restricted T Cell Immunity Mediated by Retroviral Transfer of the αβ TCR Complex
2000
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
2014
Regulation of Receptor Fate by Ubiquitination of Activated β 2 -Adrenergic Receptor and β-Arrestin
2001 StandoutScienceNobel
Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase
1999 StandoutScienceNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells
1999 Science
The emergence of mass spectrometry in biochemical research.
1994
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
2003
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene.
1994
De novo design of protein homo-oligomers with modular hydrogen-bond network–mediated specificity
2016 StandoutScienceNobel
Database of T cell-defined human tumor antigens: the 2013 update.
2013
Mass spectrometry-based proteomics
2003 StandoutNature
IFN-γ enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation
2004
Active recycling of yeast Golgi mannosyltransferase complexes through the endoplasmic reticulum
2000 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
UBIQUITIN AND THE CONTROL OF PROTEIN FATE IN THE SECRETORY AND ENDOCYTIC PATHWAYS
1998
Does the Immune System See Tumors as Foreign or Self?
2003
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
Cancer Genome Landscapes
2013 StandoutScience
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Analysis of Proteins and Proteomes by Mass Spectrometry
2001
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Glycosylation and the Immune System
2001 Science
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
2006
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Hepatitis C Virus Envelope Glycoprotein E1 Originates in the Endoplasmic Reticulum and Requires Cytoplasmic Processing for Presentation by Class I MHC Molecules
1999 StandoutNobel
A unique tumor antigen produced by a single amino acid substitution
1995
Introduction of a Glycosylation Site into a Secreted Protein Provides Evidence for an Alternative Antigen Processing Pathway: Transport of Precursors of Major Histocompatability Complex Class I–Restricted Peptides from the Endoplasmic Reticulum to the Cytosol
1997
An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database
1994 Standout
Enhancement of Antitumor Immunity by CTLA-4 Blockade
1996 StandoutScienceNobel
Compact Biocompatible Quantum Dots Functionalized for Cellular Imaging
2008 StandoutNobel
Mass Spectrometry in Proteomics
2001
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
2014
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Serological analysis of human tumor antigens: molecular definition and implications
1997
Point Mutation in Essential Genes with Loss or Mutation of the Second Allele
2001
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
2000
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Human tumor antigens recognized by T lymphocytes.
1996
Works of Jonathan Skipper being referenced
Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development
1998
A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer
2005
Identification of a Graft Versus Host Disease-Associated Human Minor Histocompatibility Antigen
1995 Science
The Immunodominant Antigen of an Ultraviolet-induced Regressor Tumor Is Generated by a Somatic Point Mutation in the DEAD Box Helicase p68
1997
Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100.
1996
Cryptic CTL Epitope on a Murine Sarcoma Meth A Generated by Exon Extension as a Novel Mechanism
2003
Mass‐spectrometric evaluation of HLA‐A*0201‐associated peptides identifies dominant naturally processed forms of CTL epitopes from MART‐1 and gp100
1999
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51
2002
An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.
1996
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones
2004
Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
1994 Science